Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page
- Check4 days agoChange DetectedNo significant changes detected in the study details page between the old and new screenshots.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check40 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated the page from Revision: v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed as a minor UI cleanup.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated to include new drug information for Fenfluramine and resources related to Dravet syndrome, while removing previous references to Fenfluramine hydrochloride and CDKL5 Deficiency Disorder. Additionally, the facility name and location details have been revised.SummaryDifference4%

Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.